Supermarket chain settles pay-for-delay suit over birth control pill

Dutch supermarket owner Ahold Delhaize has agreed to settle a series of patent infringement suits filed against pharmaceutical companies including Warner Chilcott and Watson over contraceptive pill Loestrin 24 Fe.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Allergan agrees to pay $300m to end birth control litigation

8 January 2020 Allergan’s Warner Chilcott and Watson subsidiaries have agreed to pay $300 million to end antitrust litigation centering on contraceptive pills Loestrin 24 Fe and Minastrin 24 Fe.

Americas

First Circuit says Actavis pay-for-delay ruling applies to non-cash settlements

23 February 2016 The US Court of Appeals for the First Circuit has revived claims that pay-for-delay settlements involving pharmaceutical company Warner Chilcott may be in breach of competition law, despite the deals not including cash payments.

More on this story

Americas

Allergan agrees to pay $300m to end birth control litigation

8 January 2020 Allergan’s Warner Chilcott and Watson subsidiaries have agreed to pay $300 million to end antitrust litigation centering on contraceptive pills Loestrin 24 Fe and Minastrin 24 Fe.

Americas

First Circuit says Actavis pay-for-delay ruling applies to non-cash settlements

More on this story

Americas

Allergan agrees to pay $300m to end birth control litigation

8 January 2020 Allergan’s Warner Chilcott and Watson subsidiaries have agreed to pay $300 million to end antitrust litigation centering on contraceptive pills Loestrin 24 Fe and Minastrin 24 Fe.

Americas

First Circuit says Actavis pay-for-delay ruling applies to non-cash settlements